Reference
1. Sillman FH, Sedlis A, Boyce JG. A review of lower genital
intraepithelial neoplasia and the use of topical 5-fluorouracil.Obstetrical & gynecological survey . Apr 1985;40(4):190-220.
doi:10.1097/00006254-198504000-00002
2. Sugase M, Matsukura T. Distinct manifestations of human
papillomaviruses in the vagina. International journal of cancer .
Jul 29 1997;72(3):412-5.
doi:10.1002/(sici)1097-0215(19970729)72:3<412::aid-ijc7>3.0.co;2-s
3. Daling JR, Madeleine MM, Schwartz SM, et al. A population-based study
of squamous cell vaginal cancer: HPV and cofactors. Gynecologic
oncology . Feb 2002;84(2):263-70. doi:10.1006/gyno.2001.6502
4. Strander B, Andersson-Ellström A, Milsom I, Sparén P. Long term risk
of invasive cancer after treatment for cervical intraepithelial
neoplasia grade 3: population based cohort study. BMJ (Clinical
research ed) . Nov 24 2007;335(7629):1077.
doi:10.1136/bmj.39363.471806.BE
5. Henson D, Tarone R. An epidemiologic study of cancer of the cervix,
vagina, and vulva based on the Third National Cancer Survey in the
United States. American journal of obstetrics and gynecology . Nov
1 1977;129(5):525-32.
6. Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of
tumours of female reproductive organs. 4th eds. IARC Press; 2014:
8‐253.
7. Ao M, Zheng D, Wang J, Gu X, Xi M. Risk factors analysis of
persistence, progression and recurrence in vaginal intraepithelial
neoplasia. Gynecologic oncology . Sep 2021;162(3):584-589.
doi:10.1016/j.ygyno.2021.06.027
8. Gunderson CC, Nugent EK, Elfrink SH, Gold MA, Moore KN. A
contemporary analysis of epidemiology and management of vaginal
intraepithelial neoplasia. American journal of obstetrics and
gynecology . May 2013;208(5):410.e1-6. doi:10.1016/j.ajog.2013.01.047
9. Aho M, Vesterinen E, Meyer B, Purola E, Paavonen J. Natural history
of vaginal intraepithelial neoplasia. Cancer . Jul 1
1991;68(1):195-7.
doi:10.1002/1097-0142(19910701)68:1<195::aid-cncr2820680135>3.0.co;2-l
10. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System:
terminology for reporting results of cervical cytology. Jama . Apr
24 2002;287(16):2114-9. doi:10.1001/jama.287.16.2114
11. Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low
and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia
(VIN and VaIN). The American journal of surgical pathology . Dec
2006;30(12):1513-8. doi:10.1097/01.pas.0000213291.96401.48
12. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S.
Prevalence and type distribution of human papillomavirus in carcinoma
and intraepithelial neoplasia of the vulva, vagina and anus: a
meta-analysis. International journal of cancer . Apr 1
2009;124(7):1626-36. doi:10.1002/ijc.24116
13. Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human
papillomavirus type-distribution in vulvar and vaginal cancers and their
associated precursors. Obstetrics and gynecology . Apr
2009;113(4):917-924. doi:10.1097/AOG.0b013e31819bd6e0
14. Chao A, Chen TC, Hsueh C, et al. Human papillomavirus in vaginal
intraepithelial neoplasia. International journal of cancer . Aug 1
2012;131(3):E259-68. doi:10.1002/ijc.27354
15. Bertoli HK, Rasmussen CL, Sand FL, et al. Human papillomavirus and
p16 in squamous cell carcinoma and intraepithelial neoplasia of the
vagina. International journal of cancer . Jul 1 2019;145(1):78-86.
doi:10.1002/ijc.32078
16. Serrano B, de Sanjosé S, Tous S, et al. Human papillomavirus
genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in
female anogenital lesions. European journal of cancer (Oxford,
England : 1990) . Sep 2015;51(13):1732-41.
doi:10.1016/j.ejca.2015.06.001
17. Alemany L, Saunier M, Tinoco L, et al. Large contribution of human
papillomavirus in vaginal neoplastic lesions: a worldwide study in 597
samples. Eur J Cancer . Nov 2014;50(16):2846-54.
doi:10.1016/j.ejca.2014.07.018
18. Chen Y, Li S, Zheng J, Xue H, Chen J, Zheng X. Prevalence of
multiple human papillomavirus infections and association with cervical
lesions among outpatients in Fujian, China: A cross-sectional study.Journal of medical virology . Dec 2022;94(12):6028-6036.
doi:10.1002/jmv.28062
19. Bertoli HK, Baandrup L, Aalborg GL, Kjaer AK, Thomsen LT, Kjaer SK.
Time trends in the incidence and survival of vaginal squamous cell
carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark -
A nationwide population-based study. Gynecologic oncology . Sep
2020;158(3):734-739. doi:10.1016/j.ygyno.2020.05.683
20. Deng C, Chen X, Liu Y. Human papillomavirus vaccination: coverage
rate, knowledge, acceptance, and associated factors in college students
in mainland China. Human vaccines & immunotherapeutics . Mar 4
2021;17(3):828-835. doi:10.1080/21645515.2020.1797368
21. Ebisch RMF, Rutten DWE, IntHout J, et al. Long-Lasting Increased
Risk of Human Papillomavirus-Related Carcinomas and Premalignancies
After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based
Cohort Study. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology . Aug 1 2017;35(22):2542-2550.
doi:10.1200/jco.2016.71.4543
22. Sand FL, Munk C, Jensen SM, Svahn MF, Frederiksen K, Kjær SK.
Long-Term Risk for Noncervical Anogenital Cancer in Women with
Previously Diagnosed High-Grade Cervical Intraepithelial Neoplasia: A
Danish Nationwide Cohort Study. Cancer epidemiology, biomarkers &
prevention : a publication of the American Association for Cancer
Research, cosponsored by the American Society of Preventive Oncology .
Jul 2016;25(7):1090-7. doi:10.1158/1055-9965.epi-15-1291
23. Ciavattini A, Di Giuseppe J, Marconi C, et al. Hysterectomy for
cervical intraepithelial neoplasia: A retrospective observational
multi-institutional study. International journal of gynaecology
and obstetrics: the official organ of the International Federation of
Gynaecology and Obstetrics . Dec 2022;159(3):679-688.
doi:10.1002/ijgo.14233
24. Schockaert S, Poppe W, Arbyn M, Verguts T, Verguts J. Incidence of
vaginal intraepithelial neoplasia after hysterectomy for cervical
intraepithelial neoplasia: a retrospective study. American journal
of obstetrics and gynecology . Aug 2008;199(2):113.e1-5.
doi:10.1016/j.ajog.2008.02.026
25. Alfonzo E, Holmberg E, Sparén P, Milsom I, Strander B. Risk of
vaginal cancer among hysterectomised women with cervical intraepithelial
neoplasia: a population-based national cohort study. BJOG : an
international journal of obstetrics and gynaecology . Mar
2020;127(4):448-454. doi:10.1111/1471-0528.16028
26. Liang LA, Einzmann T, Franzen A, et al. Cervical Cancer Screening:
Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and
Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.Cancer epidemiology, biomarkers & prevention : a publication of
the American Association for Cancer Research, cosponsored by the
American Society of Preventive Oncology . Mar 2021;30(3):474-484.
doi:10.1158/1055-9965.Epi-20-1003
27. Koliopoulos G, Nyaga VN, Santesso N, et al. Cytology versus HPV
testing for cervical cancer screening in the general population.The Cochrane database of systematic reviews . Aug 10
2017;8(8):Cd008587. doi:10.1002/14651858.CD008587.pub2
28. Ao M, Zheng D, Wang J, Gu X, Xi M. A retrospective study of cytology
and HPV genotypes results of 3229 vaginal intraepithelial neoplasia
patients. Journal of medical virology . Aug 30
2021;doi:10.1002/jmv.27311
29. Zhang L, Wang Q, Zhang H, Xie Y, Sui L, Cong Q. Screening History in
Vaginal Precancer and Cancer: A Retrospective Study of 2131 Cases in
China. Cancer management and research . 2021;13:8855-8863.
doi:10.2147/cmar.S335701
30. Frega A, French D, Piazze J, Cerekja A, Vetrano G, Moscarini M.
Prediction of persistent vaginal intraepithelial neoplasia in previously
hysterectomized women by high-risk HPV DNA detection. Cancer
letters . May 8 2007;249(2):235-41. doi:10.1016/j.canlet.2006.09.003
31. Khan MJ, Massad LS, Kinney W, et al. A common clinical dilemma:
Management of abnormal vaginal cytology and human papillomavirus test
results. Gynecologic oncology . May 2016;141(2):364-370.
doi:10.1016/j.ygyno.2015.11.023
32. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based
Management Consensus Guidelines for Abnormal Cervical Cancer Screening
Tests and Cancer Precursors. Journal of lower genital tract
disease . Apr 2020;24(2):102-131. doi:10.1097/lgt.0000000000000525
Figure 1 The prevalence of hr-HPV genotype in total VaIN(A) , VaIN1(B)
and VaIN2+(C). hr-HPV, high-risk human papillomavirus
Table 1 Clinical characteristics of patients with vaginal
intraepithelial neoplasia